UK Laboratory Dispatch:
UK Legal Matrix
PeptidesUK.org
British Clinical Chemical Registry
Peptide Works UK verified laboratory supplier logo
Audited UK Commercial PartnerHPLC Purity ≥98.8%Est. 2020

Peptide Works

Manchester, United Kingdom·Domain: peptide-works.com

Specialized Northern England chemical laboratory supplying solid-phase synthesized peptide chains with full sequence verification and rigorous moisture controls for academic and biotech assays.

Analytical Standards
≥98.8% HPLC
  • Automated solid-phase peptide synthesis (SPPS) sequence confirmation via Edman degradation and MS/MS
  • Reverse-phase HPLC integration spectra verifying chromatographic purity ≥98.5%
  • Karl Fischer volumetric titration measuring residual lyophilization moisture (<3.5%)
  • Lot traceability with digital analytical certificate archive accessible 24/7
Packaging & Cold-Chain
Type I Glass

High-grade neutral glass lyophilization vials capped with bromobutyl elastomer stoppers and anodized aluminum rings.

Tamper-evident crimp seals & desiccant preservation verified.
UK Express Dispatch
Tracked 24
  • United Kingdom (Next Day Tracked)
  • European Union
Cold-pack insulated packaging for temperature-sensitive reagents.

Official Research Categories at Peptide Works

Audited Catalog Inventory

Reagents Verified with Peptide Works (7)

≥98.8% Third-Party Assay Guaranteed
Mixed Pre-ClinicalCAS 137525-51-0

BPC-157

Body Protection Compound-157 Pentadecapeptide

C62H98N16O221419.55 g/molTissue Repair & Angiogenesis

BPC-157 is a stable 15-amino acid synthetic pentadecapeptide fragment originally derived from human gastric juice protein BPC. Evaluated in UK academic and biotechnology laboratories as an analytical benchmark for focal adhesion kinase (FAK) activation and endothelial tube formation assays.

Verified UK Sourcing Partners:
PharmaGrade Store (≥99.2% (HPLC))Direct Peptides (≥99.1% (HPLC))Direct Sarms (≥98.8% (HPLC))Peptide Works (≥99.0% (HPLC))PharmaLab Global (≥99.4% (HPLC))
View Full Technical Monograph
Mixed Pre-ClinicalCAS 77591-33-4

TB-500

Thymosin Beta-4 Active Hexapeptide Domain (Ac-LKKTET-OH)

C212H350N56O78S4963.50 g/molTissue Repair & Angiogenesis

TB-500 represents the synthetic active fragment of Thymosin Beta-4, a major physiological actin-sequestering protein. Studied in British biomedical research for its ability to regulate G-actin polymerization, promote keratinocyte migration, and downregulate myofibroblast differentiation.

Verified UK Sourcing Partners:
PharmaGrade Store (≥99.0% (HPLC))Direct Peptides (≥98.9% (HPLC))Direct Sarms (≥98.5% (HPLC))Peptide Works (≥98.8% (HPLC))PharmaLab Global (≥99.2% (HPLC))
View Full Technical Monograph
Human Trial DataCAS 80714-61-0

Semax

Heptapeptide ACTH(4-10) Analog (Met-Glu-His-Phe-Pro-Gly-Pro)

C37H51N9O10S813.92 g/molNeuropeptides & CNS Signaling

Semax is a synthetic regulatory heptapeptide structurally derived from an adrenocorticotropic hormone fragment (ACTH 4-10) stabilized with a C-terminal Pro-Gly-Pro tripeptide. Examined in neuropharmacology laboratories for its modulation of BDNF, trkB receptors, and cerebral monoamines.

Verified UK Sourcing Partners:
PharmaGrade Store (≥99.1% (HPLC))Direct Peptides (≥99.0% (HPLC))Direct Sarms (≥98.6% (HPLC))Peptide Works (≥98.9% (HPLC))PharmaLab Global (≥99.3% (HPLC))
View Full Technical Monograph
Human Trial DataCAS 129954-34-3

Selank

Synthetic Tuftsin Heptapeptide Analogue (Thr-Lys-Pro-Arg-Pro-Gly-Pro)

C33H57N11O9751.88 g/molNeuropeptides & CNS Signaling

Selank is a synthetic regulatory heptapeptide derived from the immunomodulatory tetrapeptide tuftsin, extended with a C-terminal Pro-Gly-Pro tripeptide. Examined in neuroimmunology laboratories for its allosteric modulation of GABAA receptors, enkephalinase inhibition, and IL-6 expression.

Verified UK Sourcing Partners:
PharmaGrade Store (≥99.2% (HPLC))Direct Peptides (≥99.0% (HPLC))Direct Sarms (≥98.6% (HPLC))Peptide Works (≥98.9% (HPLC))PharmaLab Global (≥99.3% (HPLC))
View Full Technical Monograph
Mixed Pre-ClinicalCAS 307297-39-8

Epithalon

Synthetic Pineal Tetrapeptide (Ala-Glu-Asp-Gly)

C14H22N4O9390.35 g/molCellular Longevity & Mitochondrial Axis

Epithalon (Epitalon) is a synthetic tetrapeptide modeled on the endogenous pineal extract epithalamin. Studied extensively in biogerontology laboratories for its ability to overcome the Hayflick limit via telomerase catalytic subunit (hTERT) transcription and chromatin remodeling.

Verified UK Sourcing Partners:
PharmaGrade Store (≥99.4% (HPLC))Direct Peptides (≥99.2% (HPLC))Direct Sarms (≥98.8% (HPLC))Peptide Works (≥99.1% (HPLC))PharmaLab Global (≥99.5% (HPLC))
View Full Technical Monograph
Human Trial DataCAS 2023788-19-2

Tirzepatide

Dual GIP and GLP-1 Receptor Co-Agonist 39-AA Synthetic Peptide

C225H348N48O684813.45 g/molMetabolic & Incretin Signaling

Tirzepatide is a synthetic 39-amino-acid unimolecular dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor co-agonist conjugated to a C20 fatty diacid moiety. Studied extensively in UK biochemical and pharmaceutical research for receptor affinity dynamics.

Verified UK Sourcing Partners:
PharmaGrade Store (≥99.3% (HPLC))Direct Peptides (≥99.2% (HPLC))Direct Sarms (≥98.8% (HPLC))Peptide Works (≥99.0% (HPLC))PharmaLab Global (≥99.5% (HPLC))
View Full Technical Monograph
Human Trial DataCAS 910463-68-2

Semaglutide

Acylated GLP-1 Analogue (31-AA Chain with C18 Diacid Spacer)

C187H291N45O594113.58 g/molMetabolic & Incretin Signaling

Semaglutide is a synthetic long-acting glucagon-like peptide-1 (GLP-1) receptor agonist modified at position 8 with alpha-aminoisobutyric acid (Aib) and acylated at Lys26 with a C18 fatty diacid chain. Studied in UK endocrinology and metabolic research as a classical mono-incretin reference standard.

Verified UK Sourcing Partners:
PharmaGrade Store (≥99.2% (HPLC))Direct Peptides (≥99.1% (HPLC))Direct Sarms (≥98.7% (HPLC))Peptide Works (≥98.9% (HPLC))PharmaLab Global (≥99.4% (HPLC))
View Full Technical Monograph